Safety and Efficacy of Pucotenlimab in pLECC
NCT06969534
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Lymphoepithelioma-like Carcinoma
Lymphoepithelioma
Carcinoma
Interventions
DRUG:
Pucotenlimab combined with GP regimen
Sponsor
Sun Yat-sen University